MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Free-Viewing Eye Tracking and the Effect of Levodopa in Parkinson’s Disease

A. Gallagher, H. Elliott, J. Inocentes, C. O'Keeffe, B. Coe, D. Brien, B. White, H. Riek, R. Walsh, T. Lynch, R. Reilly, D. Munoz, C. Fearon (Dublin 7, Ireland)

Meeting: 2024 International Congress

Abstract Number: 1844

Keywords: Blink rate, Eye movement, Levodopa(L-dopa)

Category: Phenomenology and Clinical Assessment of Movement Disorders

Objective: The objective of our study is to determine whether differences in oculomotor function and blink rate correlate to the off-and on- medication state in a cohort of people with Parkinson’s disease (PD).

Background: Quantitative assessment of eye movements may be a simple, reliable and sensitive clinical biomarker for PD but the effect of levodopa on naturalistic eye movements. We use a free-viewing task where participants are instructed to watch a series of brief video clips presented on a computer monitor while recording their eye movements and blink rate. A recently identified signature of oculomotor parameters in PD may differentiate it from other neurodegenerative conditions. This study focuses on whether these parameters correlate with the off- and on- state relating to levodopa therapy.

Method: A cohort of 17 patients with PD performed a free viewing paradigm in addition to detailed clinical examination including MDS-UPDRS III. The task was performed after overnight withdrawal of levodopa for the previous 12 hours and subsequently in the on-state after a levodopa challenge test. Correlation between saccade amplitude and velocity and blink rate with MDS-United Parkinson’s Disease Rating Scale and cognitive scales were undertaken. This study was funded by the Edmond J. Safra Foundation and the Michael J. Fox Foundation for Parkinson’s Research.

Results: We demonstrate differences in oculomotor function between the off-state and on-state in the PD cohort.

Conclusion: This study suggests that oculomotor dynamics and blink rate in PD have utility as clinically relevant measures which correlate with the off– and on-levodopa state.

To cite this abstract in AMA style:

A. Gallagher, H. Elliott, J. Inocentes, C. O'Keeffe, B. Coe, D. Brien, B. White, H. Riek, R. Walsh, T. Lynch, R. Reilly, D. Munoz, C. Fearon. Free-Viewing Eye Tracking and the Effect of Levodopa in Parkinson’s Disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/free-viewing-eye-tracking-and-the-effect-of-levodopa-in-parkinsons-disease/. Accessed May 19, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/free-viewing-eye-tracking-and-the-effect-of-levodopa-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley